Opthalmology

From childhood myopia to glaucoma, SCRI has been involved in a variety of ophthalmology studies

Risk factors for progressive myopia in the atropine therapy for myopia study

Loh KL, Lu Q, Tan D, Chia A. Am J Ophthalmol. 2015;159(5):945-9.

A cluster randomized controlled trial evaluating an incentive-based outdoor physical activity program to increase outdoor time and prevent myopia in children

Ngo CS, Pan CW, Finkelstein EA, Lee CF, Wong IB, Ong J, Ang M, Wong TY, Saw SM. Ophthalmic and Physiological Optics 2014, 34:362-368.

Comparative efficacy and tolerability of topical prostaglandin analogues for primary open angle glaucoma and ocular hypertension

Lin L, Zhao YJ, Chew PT, Sng CC, Wong HT, Yip LW, Wu TS, Bautista D, Teng M, Khoo AL, Lim BP. Annals of Pharmacotherapy 2014, 48(12):1585 - 1593.

Ophthalmic randomized controlled trials reports: The statement of the hypothesis

Lee CF, Cheng ACO, Fong DYT. American Journal of Ophthalmology, 2014, 157:254-259

Atropine for the treatment of childhood myopia: Changes after stopping Atropine 0.01%, 0.1% and 0.5%

Chia A, Chua WH, Li W, Fong A, Goon YY, Tan D. American Journal of Ophthalmology 2014, 157(2): 451-457.

Longitudinal changes in anterior chamber depth and axial length in Asian subjects after trabeculectomy surgery

Husain R, Li W, Gazzard G, Foster PJ, Chew PT, Oen FT, Phillips R, et al. Br J Ophthalmol 2013;97(7):852–6.

Effect of prophylactic laser iridotomy on corneal endothelial cell density over 3 years in primary angle closure suspects

Kumar RS, Baskaran M, Friedman DS, Xu Y, Wong HT, Lavanya R et al. Br J Ophthalmol 2013;97(3): 258-261.

Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study

Chia A, Li W, Tan D, Luu CD. Doc Ophthalmol 2013; 126(3):177-86.

Eyes or subjects: are ophthalmic randomized controlled trials properly designed and analyzed?

Lee CF, Cheng AC, Fong DY. Ophthalmology. 2012;119(4):869-72.

Comparison of measurements of time outdoors and light levels as risk factors for myopia in young Singapore children

Dharani R, Lee CF, Thian ZX, Drury VB, Ngo C, Sandar Mya, Wong TY Finkelstain EA, Saw SM. Eye (Lond). 2012;26(7):911-8.

Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)

Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, Tan D. Ophthalmology. 2012;119(2):347-54.

Ocular component growth curves among Singapore children with different refractive error status

Wong HB, Machin D, Tan SB, Wong TY, Saw SM. Investigative Ophthalmology and Visual Science. 2010;51(3):1341-7.

A randomized cross-over study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma

How AC, Kumar RS, Chen YM, Su DH, Gao H, Oen FT, Ho CL, Seah SK, Aung T. Br J Ophthalmol. 2009;93(6):782-6.

Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine

Tong L, Huang XL, Koh ALT, Zhang X, Tan DTH, Chua WH. Ophthalmology. 2009;116(3):572-9.

Visual impairment and its impact on health-related quality of life in adolescents

Wong HB, Machin D, Tan SB, Wong TY, Saw SM. Am J Ophthalmol. 2009;147(3):505-511.

The Singapore 5-fluorouracil trabeculectomy study – effects on intraocular pressure control and disease progression at 3 years

Wong TLT, Khaw PT, Aung T, Foster PJ, Htoon HM, Oen FTS, Gazzard G, Husain R, Devereux JG, Minassian D, Tan SB, Chew PTK, Seah SKL. Ophthalmology. 2009; 116(2):175-84.

Screening for narrow angles in the Singapore population: evaluation of new noncontact screening methods

Lavanya R, Foster PJ, Sakata LM, Friedman DS, Kashiwagi K, Wong TY, Aung HT, Alfred T, Gao H, Ee AG, Seah SK, Aung T. Ophthalmology. 2008; 115(10):1720-7, 1727.e1-2.